ClinicalTrials.gg
RecruitingNCT06853405NUTRIMINDUpdated Dec 5, 2025

Nutrition-based Interventions to Prevent Cognitive Decline

An interventional study of Nutrition-related lifestyle group sessions and Cognitive training in Cognitive Dysfunction, Cognition Disorder and Memory Disorders, sponsored by Instituto de Saude Publica da Universidade do Porto. Recruiting at 2 sites in Portugal. Open to participants aged 55 Years to 85 Years. Per ClinicalTrials.gov, last updated 2025-12-05.

Sponsored by Instituto de Saude Publica da Universidade do Porto · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by May 2026, 6 months ago, but the record still lists the study as recruiting.
  • Started Jan 2025; still recruiting 1 year 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
55 Years to 85 Years
Sex
All
01

Study summary

This study intends to evaluate the feasibility and the effectiveness of an innovative and integrated nutrition-based intervention addressing key modifiable risk factors for dementia while meeting participants' preferences for nutrition-related sessions. The intervention will include lifestyle group sessions regarding nutrition education and physical activity, individualized cognitive training at home, as well as clinical nutrition consultations.

Read the detailed description

The present project is a randomized controlled trial (RCT) to study the feasibility and effectiveness of a 6-month nutrition-based intervention designed to prevent cognitive decline in adults at higher risk of dementia.

Eligible individuals (n=120) recruited at primary health care centers or in the community will be randomized (1:1) into two arms: intervention and control groups.

The intervention group will be invited to participate in nutrition-based sessions of 180-minutes per week, directed by a nutritionist, to improve participants' skills in preparing healthy meals and reduce sedentary behaviours. Participants will also be asked to perform cognitive training at home and to attend individualized clinical nutrition consultations.

The control group will participate in data assessment and will receive a healthy recipes cookbook to thank for their participation. They will also receive an invitation to participate in free healthy cooking workshops, which will be offered upon the completion of the primary data collection endpoint.

Both groups will continue receiving the usual standard care in their healthcare unit.

Participants' assessments will be performed at baseline and will be repeated at the end of intervention (6 months after the beginning of the intervention). A follow-up assessment will be conducted 6 months after the intervention concludes. Adherence outcomes, as well as lifestyle, health and anthropometric data, cognitive performance, subjective memory complaints, anxiety and depression, quality of life and self-reported physical activity will be evaluated.

02

Conditions studied

  • Cognitive Dysfunction
  • Cognition Disorder
  • Memory Disorders
  • Cognitive Impairment
  • Neurocognitive Disorders

Keywords

  • Healthy Aging
  • Dementia
  • Cognitive Dysfunction
  • Diet, Food and Nutrition
  • Diet, Mediterranean
  • Randomized Controlled Trial
03

In context

Cognitive Dysfunction

3,872 studies on the registry are indexed under Cognitive Dysfunction; 1,119 are open to participants now.

This study's planned enrollment of 120 is above the median of 64 across 2,794 interventional studies indexed under Cognitive Dysfunction.

Browse Cognitive Dysfunction studies →

Lead sponsor

Instituto de Saude Publica da Universidade do Porto is the lead sponsor of 7 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
55 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged from 55 to 85 years old;
  • At least 4 years in the regular school system;
  • Higher individual risk for dementia defined as a score ≥6 points on the Cardiovascular Risk Factors, Aging and Dementia Dementia Risk Score (CAIDE).

Exclusion criteria

Exclusion Criteria:

  • (MoCA) score lower than the validated cutoff points defined as 2 standard deviations below the normative reference value for the corresponding age and education in the Portuguese population;
  • Having a medical condition limiting the participation in the intervention (e.g., blindness, amputation…);
  • Lack of autonomy in daily activities;
  • Diagnosis of dementia or major incapacity.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    NUTRIMIND

    The NUTRIMIND arm will be invited to receive a multidomain nutrition-based intervention to prevent cognitive decline, including lifestyle group sessions of nutrition education, daily activities to reduce physical inactivity, as well as individualized cognitive training and individualized clinical nutrition consultations. They will continue receiving the usual standard care in their healthcare unit.

    Behavioral: Nutrition-related lifestyle group sessions · Behavioral: Cognitive training · Behavioral: Clinical nutrition consultations

  • No intervention
    Control

    The control arm will receive a healthy recipe cookbook and will also be invited to attend free healthy cooking workshops after the data collection phase concludes. And will continue receiving the usual standard care in their healthcare unit.

Interventions

  • BehavioralNutrition-related lifestyle group sessions

    In person lifestyle group sessions of 180-minutes per week, directed by a nutritionist, and comprising: 1. nutrition education session for preparing healthy meals, followed by a period of social interaction while consuming the meals prepared. Participants will be encouraged to apply the healthy cooking techniques covered in each session in their home context. 2. daily activities to reduce physical inactivity (e.g., walking to the supermarket to buy ingredients, playing traditional games, caring for community gardening, among others).

  • BehavioralCognitive training

    Individualized cognitive training performed remotely, at home on their own. The participants will be invited to perform cognitive training exercises at least twice a week using COGWEB®, an online platform for cognitive training. For those unable to use computer devices, similar exercises will be available in paper-and-pencil format.

  • BehavioralClinical nutrition consultations

    A registered nutritionist will conduct individualized clinical nutrition consultations to each participant three times over the course of the study period.

06

What researchers measure

Primary outcomes

  1. Self-reported adherence to the Mediterranean Diet

    Variation of participant's self-reported adherence to the Mediterranean diet, assessed using the Mediterranean food pattern scale (MEDAS), between the baseline assessment and the end of the intervention. This scale varies from 0 (lowest adherence to the Mediterranean diet) to 14 points (highest adherence to the Mediterranean diet). A score ≥ 10 points indicates good adherence to the Mediterranean diet.

    Time frame: Up to 6 months

  2. Self-reported quality of life

    Variation of participant's quality of life, assessed using the EuroQol Group scale - 5 dimensions (EQ-5D) scale, between the baseline assessment and the end of the intervention. This scale is subdivided into two subscales: a) five multiple choice questions, with five response possibilities, which produce a score that varies from 5 (best score) to 25 points (worst score); b) visual analogic scale, that varies from 0 (worst score) to 100 (best score).

    Time frame: Up to 6 months

Secondary outcomes

  1. Self-reported memory complaints

    Variation of the self-reported memory complaints, assessed using the Subjective Memory Complaints Scale, between the baseline assessment and the end of the intervention. This scale varies from 0 (best score) to 21 points (worst score). Scores \> 3 points indicate the presence of self-reported memory complaints.

    Time frame: Up to 6 months

  2. Cognitive performance 1

    Participant's cognitive performance assessed using the Montreal Cognitive Assessment, between the baseline assessment and the end of the intervention. In this scale the worst cognitive performance is equal to 0 and the best cognitive performance is equal to 30 points.

    Time frame: Up to 6 months

  3. Cognitive performance 2

    Variation of participant's cognitive performance assessed using the Portuguese version of Addenbrooke's Cognitive Examination - Revised (ACE-R), between the baseline assessment and the end of the intervention. This brief test evaluates the following cognitive subdomains: attention and orientation, memory, fluency, language and visuospatial. The test is scored from 0 to 100 points (highest possible score). Higher scores will indicate better cognitive performance.

    Time frame: Up to 6 months

  4. Anxiety and depression symptoms

    Variation of the anxiety and depression scores, assessed using the Hospital Anxiety and Depression Scale (HADS), between the baseline assessment and the end of the intervention. This scale varies from 0 (best score) to 21 points (worst score).

    Time frame: Up to 6 months

  5. Blood Pressure

    Variation of participant's systolic and diastolic blood pressure, between the baseline evaluation and the end of the intervention.

    Time frame: Up to 6 months

  6. Body Mass Index

    Variation of participant's body mass index between the baseline assessment and the end of the intervention.

    Time frame: Up to 6 months

  7. Self-reported physical activity

    Variation of participants' self-reported physical activity using the short version of the International Physical Activity Questionnaire (IPAQ), between baseline and the end of the intervention. Participants will be classified into 3 levels of physical activity: inactive, minimally active and active.

    Time frame: Up to 6 months

  8. Health Literacy

    Variation of participant's health literacy Portuguese validated version of the NVS - Newest Vital Sign between baseline assessment and the end of the intervention. The NVS includes six questions regarding an ice cream nutrition label. The scores range from 0 to 6 (1 point for each correct answer): a score of 0 - 1 suggests high likelihood of limited literacy; 2 - 3 indicates the possibility of limited literacy; and 4 - 6 almost always indicates adequate literacy.

    Time frame: Up to 6 months

  9. Nutrition Knowledge on Mediterranean Diet for Cardiovascular Disease

    Variation of participants' nutrition knowledge about Mediterranean Diet and its health benefits between baseline assessment and the end of the intervention. The nutrition knowledge will be assessed using a 20-item tool, the Mediterranean Diet Nutrition Knowledge Questionnaire (Med-NKQ). In total, the tool score range from 0 to 42, with a higher score indicating greater knowledge.

    Time frame: Up to 6 months

  10. Adherence to each intervention

    Proportion of adherence to each intervention, calculated as the number of sessions attended divided by the total number of sessions implemented.

    Time frame: Up to 6 months

  11. Dropout

    Proportion of participants who dropped out of the study, calculated as the number of participants who dropped out after attending at least one session divided by the total number of participants who attended at least one session.

    Time frame: Up to 6 months

  12. Time of follow-up

    Number of days between the first and the last session attended by the participant.

    Time frame: Up to 6 months

  13. Implemented sessions

    Proportion of sessions implemented, calculated as the number of sessions that the research team was able to implement divided by the total number of sessions planned.

    Time frame: Up to 6 months

  14. Complete assessment of participants

    For each study outcome, proportion of participants with complete information, calculated at baseline and different moments of follow-up, as the number of participants with complete information divided by the total number of participants evaluated.

    Time frame: Up to 12 months

07

Study locations

2 of 2 sites recruiting
  • Instituto de Saúde Pública da Universidade do Porto
    Porto, Portugal 4000-600, Portugal
    Recruiting
    • Daniela de Sousa, Master · Contactdaniela.sousa@ispup.up.pt · +351222061820
    • Patrícia Padrão, PhD · Principal investigator
    • Ana Rute Costa, PhD · Principal investigator
  • Faculty of Nutrition and Food Sciences, University of Porto
    Porto, 4150-180, Portugal
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 5, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06853405
Lead sponsor
Instituto de Saude Publica da Universidade do Porto
Responsible party
Sponsor
First posted
Mar 3, 2025
Start date
Jan 27, 2025
Primary completion
May 2026 (estimated)
Completion
Aug 2026 (estimated)
Last update
Dec 5, 2025

Study contacts

Daniela de Sousa, Master
Contact
daniela.sousa@ispup.up.pt
+351222061820

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion